Boramae Urology

Medicine & Life Sciences

1. Prostate 100%
2. Prostatic Hyperplasia 55%
3. Volatilization 46%
4. Solid-State Lasers 42%
5. Lower Urinary Tract Symptoms 42%
6. Prostatic Neoplasms 40%
7. Prostatectomy 38%
8. Prostate-Specific Antigen 27%
9. Urodynamics 24%
10. Urinary Bladder 24%
11. Overactive Urinary Bladder 24%
12. Erectile Dysfunction 23%
13. Suburethral Slings 21%
14. Urinary Bladder Neck Obstruction 19%
15. Biopsy 19%
16. Urinary Incontinence 19%
17. Korea 18%
18. Kidney 16%
19. Tamsulosin 16%
20. Stress Urinary Incontinence 15%
21. Percutaneous Nephrolithotomy 14%
22. Internet 14%
23. Seoul 14%
24. Recurrence 14%
25. Quality of Life 13%
26. Renal Cell Carcinoma 13%
27. Crush Injuries 13%
28. Safety 13%
29. Premature Ejaculation 13%
30. Lasers 13%
31. Therapeutics 13%
32. potassium titanylphosphate 11%
33. Nerve Crush 11%
34. Lim Kinases 11%
35. Prospective Studies 11%
36. Nocturia 11%
37. Residual Volume 11%
38. Sexuality 10%
39. Neoplasm Grading 10%
40. Survival 10%
41. Fibrosis 10%
42. Actin Depolymerizing Factors 9%
43. Urge Urinary Incontinence 9%
44. Ureter 9%
45. Wounds and Injuries 9%
46. rho-Associated Kinases 9%
47. Prostatitis 8%
48. Laser Therapy 8%
49. Smooth Muscle 8%
50. Lithotripsy 8%
51. Underactive Urinary Bladder 8%
52. Multivariate Analysis 7%
53. Urinary Retention 7%
54. Margins of Excision 7%
55. Urine 7%
56. Transurethral Resection of Prostate 7%
57. Nephrectomy 7%
58. Phosphodiesterase 5 Inhibitors 7%
59. Nomograms 7%
60. Apoptosis 7%
61. Hyperplasia 7%
62. naftopidil 7%
63. Meta-Analysis 6%
64. Population 6%
65. Phosphorylation 6%
66. Solifenacin Succinate 6%
67. Vasovasostomy 6%
68. Ejaculation 6%
69. Confidence Intervals 6%
70. Morcellation 6%
71. mirodenafil 6%
72. Pressure 5%
73. Regression Analysis 5%
74. Odds Ratio 5%
75. Urinary Tract 5%
76. Linguistics 5%
77. Serum 5%
78. Ureteroscopy 5%
79. Ambulatory Monitoring 5%
80. Neoplasms 5%
81. Sildenafil Citrate 5%
82. Logistic Models 5%
83. Metabolic Syndrome 5%